TRIPLE-SWITCH (SWOG/CCTG-PR26): A randomized phase III clinical trial for the addition of docetaxel to androgen receptor pathway inhibitors in patients with metastatic castration sensitive prostate cancer (mCSPC) and suboptimal PSA response (NCT06592924). Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Ong, Michael
  • Sokolova, Alexandra
  • Hotte, Sebastien
  • Dorff, Tanya B
  • Chi, Kim N
  • Wyatt, Alexander William
  • Goldkorn, Amir
  • Kolinsky, Michael Paul
  • Brundage, Michael Donald
  • Ndika, Akunne
  • Lerner, Seth P
  • Parulekar, Wendy R
  • Ding, Keyue
  • Jafri, Mariam

publication date

  • June 2025